Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population.

O'Seaghdha CM, Hwang SJ, Bhavsar NA, Köttgen A, Coresh J, Astor BC, Fox CS.

Am J Kidney Dis. 2011 Jun;57(6):841-9. doi: 10.1053/j.ajkd.2010.11.022. Epub 2011 Feb 3.

2.

Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.

Bhavsar NA, Köttgen A, Coresh J, Astor BC.

Am J Kidney Dis. 2012 Aug;60(2):233-40. doi: 10.1053/j.ajkd.2012.02.336. Epub 2012 Apr 28.

3.

Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).

Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG.

Am J Kidney Dis. 2012 Dec;60(6):904-11. doi: 10.1053/j.ajkd.2012.05.014. Epub 2012 Jun 30.

4.

Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study.

Foster MC, Hwang SJ, Larson MG, Lichtman JH, Parikh NI, Vasan RS, Levy D, Fox CS.

Am J Kidney Dis. 2008 Jul;52(1):39-48. doi: 10.1053/j.ajkd.2008.03.003. Epub 2008 Apr 28.

5.

Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) study.

Astor BC, Köttgen A, Hwang SJ, Bhavsar N, Fox CS, Coresh J.

Am J Nephrol. 2011;34(4):291-7. doi: 10.1159/000330699. Epub 2011 Aug 9.

6.

Lung Function and Incident Kidney Disease: The Atherosclerosis Risk in Communities (ARIC) Study.

Sumida K, Kwak L, Grams ME, Yamagata K, Punjabi NM, Kovesdy CP, Coresh J, Matsushita K.

Am J Kidney Dis. 2017 Nov;70(5):675-685. doi: 10.1053/j.ajkd.2017.05.021. Epub 2017 Jul 26.

PMID:
28754455
7.

Fibroblast growth factor 23 and incident CKD in type 2 diabetes.

Isakova T, Craven TE, Lee J, Scialla JJ, Xie H, Wahl P, Marcovina SM, Byington RP, Wolf M.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):29-38. doi: 10.2215/CJN.06190614. Epub 2014 Oct 24.

8.

Risk implications of the new CKD Epidemiology Collaboration (CKD-EPI) equation compared with the MDRD Study equation for estimated GFR: the Atherosclerosis Risk in Communities (ARIC) Study.

Matsushita K, Selvin E, Bash LD, Astor BC, Coresh J.

Am J Kidney Dis. 2010 Apr;55(4):648-59. doi: 10.1053/j.ajkd.2009.12.016. Epub 2010 Feb 26.

9.

Low ankle-brachial index and the development of rapid estimated GFR decline and CKD.

Foster MC, Ghuman N, Hwang SJ, Murabito JM, Fox CS.

Am J Kidney Dis. 2013 Feb;61(2):204-10. doi: 10.1053/j.ajkd.2012.07.009. Epub 2012 Aug 15.

10.

Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA).

Shastri S, Katz R, Shlipak MG, Kestenbaum B, Peralta CA, Kramer H, Jacobs DR Jr, de Boer IH, Cushman M, Siscovick D, Sarnak MJ.

Am J Kidney Dis. 2011 Jun;57(6):832-40. doi: 10.1053/j.ajkd.2010.11.021. Epub 2011 Feb 5.

11.

Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) Study.

Goldenstein L, Driver TH, Fried LF, Rifkin DE, Patel KV, Yenchek RH, Harris TB, Kritchevsky SB, Newman AB, Sarnak MJ, Shlipak MG, Ix JH; Health ABC Study Investigators.

Am J Kidney Dis. 2014 Oct;64(4):542-9. doi: 10.1053/j.ajkd.2014.05.009. Epub 2014 Jun 18.

12.

Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population.

Astor BC, Shafi T, Hoogeveen RC, Matsushita K, Ballantyne CM, Inker LA, Coresh J.

Am J Kidney Dis. 2012 May;59(5):653-62. doi: 10.1053/j.ajkd.2011.11.042. Epub 2012 Feb 4.

13.

Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study.

Bash LD, Astor BC, Coresh J.

Am J Kidney Dis. 2010 Jan;55(1):31-41. doi: 10.1053/j.ajkd.2009.09.006. Epub 2009 Nov 22.

PMID:
19932544
14.

CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race.

Hui X, Matsushita K, Sang Y, Ballew SH, Fülöp T, Coresh J.

Am J Kidney Dis. 2013 Oct;62(4):691-702. doi: 10.1053/j.ajkd.2013.04.010. Epub 2013 Jun 13.

15.

Dietary Acid Load and Incident Chronic Kidney Disease: Results from the ARIC Study.

Rebholz CM, Coresh J, Grams ME, Steffen LM, Anderson CA, Appel LJ, Crews DC.

Am J Nephrol. 2015;42(6):427-35. doi: 10.1159/000443746. Epub 2016 Jan 21.

16.

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, Safford MM, Zhang X, Muntner P, Warnock D.

JAMA. 2011 Apr 20;305(15):1545-52. doi: 10.1001/jama.2011.468. Epub 2011 Apr 11.

17.

Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.

Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY; Chronic Renal Insufficiency Cohort (CRIC) study investigators.

Kidney Int. 2013 May;83(5):909-14. doi: 10.1038/ki.2012.458. Epub 2013 Jan 23.

18.

Kidney Function and Fracture Risk: The Atherosclerosis Risk in Communities (ARIC) Study.

Daya N, Voskertchian A, Schneider ALC, Ballew S, McAdams DeMarco M, Coresh J, Appel LJ, Selvin E, Grams ME.

Am J Kidney Dis. 2016 Feb;67(2):218-226. doi: 10.1053/j.ajkd.2015.06.020. Epub 2015 Aug 4.

19.

Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.

Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC.

Am J Kidney Dis. 2009 Apr;53(4):596-605. doi: 10.1053/j.ajkd.2008.10.044. Epub 2008 Dec 24.

20.

Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples.

Goek ON, Köttgen A, Hoogeveen RC, Ballantyne CM, Coresh J, Astor BC.

Nephrol Dial Transplant. 2012 Jul;27(7):2839-47. doi: 10.1093/ndt/gfr795. Epub 2012 Jan 28.

Supplemental Content

Support Center